Company news

InMed Pharmaceuticals Inc. news in 2025

InMed Pharmaceuticals Inc.'s news releases, calls and decks from 2025, newest first.

View company

InMed Announces Results of 2025 Annual General and Special Meeting

December 17, 2025

InMed Provides Update on BayMedica Commercial Business

December 12, 2025

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

November 18, 2025

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

November 6, 2025

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

October 15, 2025

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

October 9, 2025

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

September 23, 2025

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025

September 16, 2025

InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

September 5, 2025

InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025

July 28, 2025

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

June 27, 2025

InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

June 25, 2025

InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

June 24, 2025

InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

June 13, 2025

InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

May 12, 2025

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

February 11, 2025

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

February 2, 2025

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds

January 21, 2025

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study

January 20, 2025

Decks in 2025